The Role of Heparan Sulfate in Lymph Node Metastasis
Author Information
Author(s): Yin Xin, Truty Jadwiga, Lawrence Roger, Johns Scott C, Srinivasan R Sathish, Handel Tracy M, Fuster Mark M
Primary Institution: University of California San Diego
Hypothesis
Heparan sulfate is a key mediator of chemokine actions in lymphatic metastasis.
Conclusion
Genetic alteration of lymphatic endothelial heparan sulfate impairs tumor cell migration and lymph node metastasis.
Supporting Evidence
- Lymphatic endothelial deficiency in Ndst1 resulted in altered lymph node metastasis in tumor-bearing mice.
- Specific immuno-localization of CCL21 showed reduced association with tumor cells in mutant lymph nodes.
- Heparan sulfate secreted by lymphatic endothelium is required for CCL21-dependent directional migration of tumor cells.
- Genetic targeting of heparan sulfate biosynthesis impaired tumor cell migration signaling pathways.
Takeaway
Heparan sulfate helps cancer cells move to lymph nodes, and changing it can stop this movement.
Methodology
The study used genetic targeting of heparan sulfate biosynthesis in lymphatic endothelial cells and assessed its effects on tumor cell migration and lymph node metastasis in mouse models.
Limitations
The study's findings may not be generalizable to all types of cancers or human conditions.
Participant Demographics
Mice were used in the study, specifically Ndst1f/fTekCre+ and Ndst1f/fTekCre- littermates.
Statistical Information
P-Value
0.016
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website